Legacy AI grade · Sources dated 2026-06-08. Not expert reviewed. Coverage is limited to the listed sources. About the new summary workflow
Galphimia glauca for Insomnia
Verdict: Insufficient Evidence
Across 2 PubMed studies, the evidence for Galphimia glauca in Insomnia grades Tier U — unverified / insufficient. Research is still too limited to draw a firm conclusion.
U ⚫ U Unverified Insufficient Evidence
Why this grade7-layer evidence engine
⚖️
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditableRaw score 0.44
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
U · Insufficient Evidence
Confidence
45%
Conflicting evidence
Evidence level
E7
Single small RCT
▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.44
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
PubMed studies (2)L2 · primary research & systematic reviews
Galphimine-B Standardized Extract versus Alprazolam in Patients with Generalized Anxiety Disorder: A Ten-Week, Double-Blind, Randomized Clinical Trial
Finding: Anxiety trial; daytime sleepiness reported only as an adverse event (4.7% G-B vs 22.2% alprazolam), not a sleep efficacy endpoint.
View on PubMed In vivo Study on Depressant Effects and Muscle Coordination Activity of Galphimia glauca Stem Methanol Extract
Finding: Extract prolonged pentobarbital-induced sleeping time, indicating CNS depressant effect; no human/clinical sleep relevance.
View on PubMed